| Volume 31(2023) > Number 4 | Biological and clinical significance of the AGE-RAGE axis in the aggressiveness and prognosis of prostate cancer | Shih-Hong Khoo, Pei-Ru Wu, Kun-Tu Yeh, Shih-Lan Hsu, Chi-Hao Wu | 664-682 |
| Volume 31(2023) > Number 4 | Dehulled Adlay (Coix lachryma-jobi L.) Ameliorates Hepatic Gluconeogenesis and Steatosis in Streptozotocin/High-Fat Diet-induced Diabetic Rats | Shing-Hwa Liu, Wan-Hsin Wu, Huei-Ping Tzeng, Wenchang Chiang, Meng-Tsan Chiang | 683-695 |
| Volume 31(2023) > Number 4 | Cryptocaryone induces apoptosis in human hepatocellular carcinoma cells by inhibiting aerobic glycolysis through Akt and c-Src signaling pathways | Shing-Hwa Liu, Wan-Hsin Wu, Huei-Ping Tzeng, Wenchang Chiang, Meng-Tsan Chiang | 696-710 |
| Volume 31(2023) > Number 4 | An integrated strategy to evaluate active substances of Astragali Radix-Carthami Flos combination on the treatment of cerebral ischemia reperfusion injury based on TQSM polypharmacokinetics | Qiang Zeng, Chang Li, Shouchao Xu, Yu He | 711-738 |
| Volume 31(2023) > Number 4 | Isolation of GLP-1 enhancing indolizidine alkaloids from Boehmeria formosana | Ching-Yi Lu, Zheng-Ying Huang, Meng-Chin Chen, Hui-Kang Liu, Shoei-Sheng Lee, Chia-Chuan Chang | 739-771 |
| Volume 31(2023) > Number 4 | Application of the US food and drug administration’s sentinel routine querying tools to the Taiwan sentinel data model-formatted national health insurance research database | Fang-Ju Lin, Ling-Ya Huang, Chi-Chuan Wang, Sengwee Toh | 772-781 |
| Volume 31(2023) > Number 4 | Acknowledgment of Reviewers | none | none |
| Volume 31(2023) > Number 4 | Corrigendum to "SSR-based molecular diagnosis for Taiwan tea cultivars and its application in identifying cultivar composition of the processed tea" | Chih-Yi Hu, Hsien-Tsung Tsai, Chui-Feng Chiu, Tsung-Chen Su, Nguyen Hoang Khoi Le, Shu-Dan Yeh | none |
| Volume 31(2023) > Number 3 | Effects of green tea–derived natural products on resistance exercise training in sarcopenia: A retrospective narrative mini-review | Hung-Wen Liu, Sue-Joan Chang | 381-386 |
| Volume 31(2023) > Number 3 | How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy | Ya-Chu Tang, Yung-Jen Chuang, Hsin-Huei Chang, Shin-Hun Juang, Gow-Chin Yen, Jang-Yang Chang, Ching-Chuan Kuo | 387-407 |